Ashwani Gujral on August 31: Buy Glenmark, ICICI Bank, Sun Pharma, NIIT Tech & Tata Steel-January 2024-www.financetom.com

Market

Ashwani Gujral on August 31: Buy Glenmark, ICICI Bank, Sun Pharma, NIIT Tech & Tata Steel

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Ashwani Gujral on August 31: Buy Glenmark, ICICI Bank, Sun Pharma, NIIT Tech & Tata Steel

Aug 30, 2018 11:59 PM

The latest analysis and commentary by stock market guru Ashwani Gujral on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Glenmark Pharma, ICICI Bank, Sun Pharma, NIIT Technologies and Tata Steel.

Follow stock recommendations by Ashwani Gujral here: https://www.cnbctv18.com/author/ashwani-gujral-115/

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

First Published:Aug 31, 2018 8:59 AM IST

Previous page： Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell Next page： XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell

Oct 21, 2025

08:09 AM EDT, 10/21/2025 (MT Newswires) -- US stock futures were little changed in Tuesday's premarket session as investors parsed pre-market earning reports and looked ahead to reports coming out later in the day and week. General Motors (GM), Coca-Cola (KO), Lockheed Martin (LMT), and Phillip Morris (PM) all reported earnings beats pre-bell. Dow Jones Industrial Average futures were up...

XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering

Oct 21, 2025

08:13 AM EDT, 10/21/2025 (MT Newswires) -- XORTX Therapeutics ( XRTX ) , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, was down near 10% in US premarket after announcing Tuesday that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale of...

US STOCKS-Wall Street futures subdued as earnings season gains momentum

Oct 21, 2025

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Futures flat: Dow up 0.03%, S&P 500 up 0.03%, Nasdaq down 0.02% * Fluor gains after reports Starboard has taken nearly 5% stake * Health insurers rise after upbeat results from Elevance (Updates prices) By Pranav Kashyap and...

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Rate-Cut Bets Offset by Earnings Watch

Oct 21, 2025

08:32 AM EDT, 10/21/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.04% and the actively traded Invesco QQQ Trust (QQQ) was 0.02% higher in Tuesday's premarket activity as hopes of an interest rate cut were offset by a focus on corporate earnings. US stock futures were mixed, with S&P...